Connect with us
Global non-profit partnership CARB-X is funding privately-held UK company Phico Therapeutics to develop a new intravenous engineered bacteriophage drug to treat
Why are some COVID-19 patients finding relief from their long-term symptoms after getting the vaccine? Experts have two theories.
While there are currently only vaccines and no drugs for use against coronavirus, researchers are in the final stage of human trial of orally-administered antiviral...
Phico Therapeutics has been awarded a grant of up to $18.2 million USD to tackle the global rising threat of drug-resistant bacteria.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better...
China had “apparently known for years” about pandemic risks which came from places like wet markets, according to Sky News host Paul Murray.It comes amid reports...
'I'm fearful of what I'm not comfortable with.'
An experimental drug to treat COVID-19, which can be taken orally, is now being tested in humans after showing early promise and effectiveness in hamsters.
At least 20 per cent of employees work atypical hours or shifts, and growing scientific evidence associates these with deleterious cardiovascular outcomes.
New variants could bring a whole host of new headaches